CAS: 3511-16-8; Hetacillin

该化合物是一个复杂的有机化合物,其特点是双环结构,包括硫磺原子(thia)和氮原子(zabilco),该化合物具有一个箱状酸功能组,有助于其酸度和潜在反应性;二甲基和苯基替代组的存在表明,它可能表现出严重的僵化障碍,影响其化学行为和相互作用; 氨碘基碘混合物表明潜在的生物活动,因为与这种结构的化合物经常被探索用于药物用途; 立体化学(2S,5R,6R)配置表明,该物质的具体空间安排可以影响化合物的特性,包括溶性,稳定性和生物活动;

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

hetacillin 6-epi-ampicillin 2-(3,6-dioxo-5-phenylpiperazine-2-yl)-5,5-dimethylthiazolidine-4-carboxylic acid hetacillin methyl ester hetacillin methyl ester S-oxide

合成工艺路线路线简述

    📜Hetacillin 在 Sodium Hydroxide体系中,反应 1.0H,以92%的收率获得6-Epi-Hetacillin
    参考文献:Chemical Reactivity Of Penicillins And Cephalosporins. Intramolecular Involvement Of The Acyl-Amido Side Chain
    标题:Chemical Reactivity Of Penicillins And Cephalosporins. Intramolecular Involvement Of The Acyl-Amido Side Chain
    摘要:The Rate Of Degradation Of B-Epi-Ampicillin In Acidic,Neutral,And Alkaline Aqueous Solutions Was Followed At 35 Degrees C And An Ionic Strength Of 0.5 Mol Dm(-3) (Kcl) By High-Performance Liquid Chromatography (Hplc) And Spectrophotometric Assays. Pseudo-First-Order Rate Constants Were Determined In A Variety Of Buffer Solutions,And The Overall Ph-Rate Profile Was Obtained By Extrapolation To Zero Buffer Concentration. The Hydrolysis Of 6-Epi-Ampicillin Is Subject To Acid And Hydroxide-Ion Catalysis And,For A Penicillin,An Unusual Ph-Independent Reaction. Intramolecular General Base-Catalyzed Hydrolysis By The Side Chain Amido Group Is Proposed To Explain The Enhanced Rate Of Neutral Hydrolysis Of 6-Epi-Ampicillin And Cephalosporins. The Beta-Lactam Of 6-Epi-Ampicillin Also Undergoes Intramolecular Aminolysis By Nucleophilic Attack Of The 6-Alpha Side Chain Amino Group To Give A Stable Piperazine-2,5-Dione Derivative. The Low Effective Molarity For Intramolecular Aminolysis Of Only 40 M Is Partly Attributed To The Unfavorable Trans To Cis Isomerization About The B-Amide Side Chain Required For Ring Closure. Theoretical Calculations Show That The Intramolecular Aminolysis Of 6-Epi-Ampicillin Nucleophilic Attack ocurs From The Alpha-Face Of The Beta-Lactam Ring With An Activation Energy Of 14.4 Kcal/Mol.
    Doi:10.1021/Jo981628J

    海关参考信息

    专利信息


    专利号:US-2005186197-A1
    优先权日:2002-08-29
    标 题:Peptide inhibitors of beta lactamases
    发明人:PALZKILL TIMOTHY; HUANG WANZHI
    摘要:Peptide inhibitors of β-lactamases have been identified by the synthesis of peptide arrays using synthesis SPOT technology. These peptide inhibitors of β-lactamase have activity against a broad spectrum of β-lactamases and are useful in a variety of applications.

    专利号:US-8017776-B2
    优先权日:2003-07-15
    标题 :Methods for synthesis of acyloxyalkyl compounds
    发明人:BHAT LAXMINARAYAN; GALLOP MARK A
    权利人:XENOPORT INC
    摘要:Disclosed herein are methods for synthesizing 1-(acyloxy)-alkyl prodrug derivatives of drugs through oxidation of 1-acyl-alkyl derivatives of drugs under anhydrous reaction conditions. The methods typically proceed stereospecifically, in high yield, do not require the use of activated intermediates and/or toxic compounds and are readily amenable to scale-up.

    专利号:US-9693999-B2
    优先权日:2011-01-26
    标题:Small molecule RNase inhibitors and methods of use
    发明人:DUNMAN PAUL M; OLSON PATRICK D; CHILDERS WAYNE
    权利人:UNIV ROCHESTER; UNIV NEBRASKA; Temple University—Of the Commonwealth System of Higher Education
    摘要:Small molecule inhibitors of bacterial ribonuclease (e.g., RnpA) and methods for their synthesis and use are described herein. The methods of using the compounds include treating and preventing microbial infections and inhibiting bacterial ribonuclease. Also described herein are methods of identifying compounds for treating or preventing a microbial infection.

    专利号:US-8143437-B2
    优先权日:2002-02-19
    标题:Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
    发明人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X
    权利人:GALLOP MARK A; XIANG JIA-NING; YAO FENMEI; BHAT LAXMINARAYAN; ZHOU CINDY X; XENOPORT INC
    摘要:The present invention provides a method for synthesizing 1-(acyloxy)-alkyl derivatives from 1-acyl-alkyl derivatives, which typically proceeds stereospecifically, in high yield, does not require the use of activated intermediates and/or toxic compounds and is readily amendable to scale-up. The current invention also provides 1-acyl-alkyl derivatives of known drug components and methods for synthesizing these 1-acyl-alkyl derivatives.

    专利号:EP-0024372-A1
    优先权日:1979-08-03
    标题:Derivatives of clavulanic acid, their preparation and pharmaceutical compositions containing them
    发明人:DENERLEY PAUL MILLINGTON; EGLINGTON ALFRED JOHN; HARBRIDGE JOHN BARRY
    权利人:BEECHAM GROUP PLC
    摘要:The compounds of the formula (II):n and salts and esters thereof wherein the hydroxyl group occupies position 2 or 4 R 1 and R 2 may be the same or different and represent hydrogen, halogen, hydroxy, lower alkyl, cyclopentyl, cyclohexyl, lower alkoxy or R, and R 2 when an adjacent carbon atoms may together represent a 1,4-buta-1,3-dienylene group or a polymethylene group containing from 3 to 5 carbon atoms; have been found to be β-lactam antibiotics and synergists with penicillins and cephalosporins. Their preparation and use is described. The synthesis of intermediates useful in their preparation is also described.

    专利号:WO-9925385-A1
    优先权日:1997-11-17
    标 题:A method of increasing nucleic acid synthesis with ultrasound
    发明人:UNGER EVAN C; MCCREERY THOMAS; SADEWASSER DAVID
    权利人:IMARX PHARMACEUTICAL CORP
    摘要:The present invention is directed to a method of increasing nucleic acid synthesis in a cell comprising administering to the cell a therapeutically effective amount of ultrasound for a therapeutically effective time such that said administration of said ultrasound results in said increased nucleic acid synthesis. The nucleic acid sequence may comprise an endogenous sequence or an exogenous sequence.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Kolar QK, Godden SM, Erskine RJ, Ruegg PL. Confirmed bacteriological diagnosis and cure of nonsevere gram-positive clinical mastitis cases enrolled in a randomized clinical trial based on results of on-farm culture. JDS Commun. 2024 May 10;5(6):628-633. doi: 10.3168/jdsc.2024-0560.
    2: Vasquez AK, Nydam DV, Capel MB, Ceglowski B, Rauch BJ, Thomas MJ, Tikofsky L, Watters RD, Zuidhof S, Zurakowski MJ. Randomized noninferiority trial comparing 2 commercial intramammary antibiotics for the treatment of nonsevere clinical mastitis in dairy cows. J Dairy Sci. 2016 Oct;99(10):8267-8281. doi: 10.3168/jds.2016-11258. Epub 2016 Aug 10. 98(3):1856-61. doi: 10.3168/jds.2014-8715. Epub 2014 Dec 26. 97(9):5426-36. doi: 10.3168/jds.2013-7756. Epub 2014 Jul 3. 82(8):1664-70. doi: 10.3168/jds.s0022-0302(99)75395-6. 81(5):963-72. 567(2):389-404. doi: 10.1016/0378-4347(91)80145-3. 15(1):15-8. doi: 10.1007/BF03190122. 128(7-8):229-31. 37(7):1827-30. doi: 10.1248/cpb.37.1827. 70(8):1696-700. doi: 10.3168/jds.S0022-0302(87)80198-4. 35(6):2366-72. doi: 10.1248/cpb.35.2366. 38(12):3497-504. Japanese. 10(1):27-32. doi: 10.1007/BF03189694. 65(2):107-14. 73(2):169-73. doi: 10.1002/jps.2600730208. 49(6):551-8. doi: 10.1007/BF00399847. 40(4):497-506. Polish. 20(2):197-204. doi: 10.1016/s0278-6915(82)80248-2. ampicillin and phenytoin--Food and Drug Administration. Final rule. Fed Regist. 1981 Jan 2;46(1):28.

    合成参考文献


    参考文献:10.1080/15376510701857262
    摘要:Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF. Development of a Phospholipidosis Database and Predictive Quantitative Structure-Activity Relationship (QSAR) Models. Toxicology Mechanisms and Methods. 2008 Jan;18(2-3):217–27. doi: 10.1080/15376510701857262.
    摘要:S55 | ZINC15PHARMA | Pharmaceuticals from ZINC15 | DOI:10.5281/zenodo.3247749
    摘要:Ross et al. JASMS 2022; 33; 1061-1072. DOI:10.1021/jasms.2c00111
    摘要:PhysProp
    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知